Bayer
German multinational pharmaceutical and biotechnology company
Follow Bayer on Notably News to receive short updates to your email — rarely!
| 2025 | Flyers from an alleged dark money source were sent to Missouri senators opposing the Roundup-related bill, with Bayer denying involvement in the mailers. |
| 2024 | Legislation was introduced in Iowa, Missouri, and Idaho with language potentially shielding Bayer from Roundup-related cancer lawsuits. |
| 2023 | Bayer experienced a revenue decline to €47.6 billion and returned to a net loss of €2.9 billion, with employee count further reducing to 99,723 |
| April 4 2023 | A Delaware judge dismissed a lawsuit by Merck & Co seeking to hold Bayer AG responsible for talc-related liabilities from a 2014 consumer care business purchase. The judge supported Bayer's interpretation of the purchase agreement, preventing Merck from transferring its legal liabilities to Bayer. |
| 2022 | Bayer achieved its highest revenue in the given period at €50.7 billion, with net income rebounding to €4.1 billion and employee count increasing to 101,369 |
| June 17 2022 | The United States Court of Appeals for the Ninth Circuit ordered the EPA to reexamine its 2020 finding that glyphosate did not pose a health risk. |
| 2021 | Bayer recovered partially, reporting revenue of €44.0 billion and a net income of €1.0 billion, with employee count stabilizing at 99,637 |
| June 2021 | Bayer announced the acquisition of Noria Therapeutics Inc. and PSMA Therapeutics Inc., gaining rights to cancer-based investigational compounds based on actinium-225. |
| 2020 | Bayer experienced a challenging year with revenue dropping to €41.4 billion and a substantial net loss of €10.4 billion, with further reduction in employee count to 99,538 |
| 2020 | Bayer sold its Animal Health business to Elanco. |
| November 25 2020 | U.S. District Judge Fernando M. Olguin rejected Bayer's $650 million settlement offer for PCB-related lawsuits and allowed the cases to proceed. |
| November 25 2020 | U.S. District Judge Stephen Limbaugh Jr. reduced the punitive damages in the Bader Farms case from $250 million to $60 million. |
| October 2020 | Bayer agreed to acquire Asklepios BioPharmaceuticals for $2 billion upfront. |
| August 2020 | Bayer acquired KaNDy Therapeutics Ltd for $425 million to boost its female healthcare business. |
| July 2020 | The California Court of Appeals denied an appeal and reduced the damages owed to $20.4 million. |
| June 2020 | Bayer agreed to pay $800 million to settle lawsuits related to PCB contamination of public waterways by Monsanto prior to 1978. |
| June 2020 | Bayer agreed to a settlement of up to $400 million for all dicamba claims from crop years 2015 to 2020, separate from the Bader Farms lawsuit. |
| June 2020 | Bayer agreed to pay $9.6 billion to settle over 10,000 Roundup lawsuits, with an additional $1.25 billion allocated for future claims. The settlement aims to resolve 75% of existing claims. |
| June 2020 | A verdict was delivered upholding the original Roundup lawsuit judgment but further reducing the award to $21.5 million. |
| February 15 2020 | Bayer and BASF were ordered to pay an additional $250 million in punitive damages in the Bader Farms lawsuit, bringing the total judgment to $265 million. The companies announced plans to appeal the fine. |
| February 14 2020 | Bayer and BASF were ordered to pay Missouri peach farmer Bill Bader $15 million in damages for destruction of his peach trees caused by dicamba usage by nearby farmers. |
| January 2020 | The US Environmental Protection Agency (EPA) finalized its interim registration review for Roundup, stating that it did not identify any cancer risks. |
| 2019 | A federal jury in San Francisco ruled in favor of Bayer in a $600 million class action lawsuit alleging misleading marketing claims about One A Day vitamins' health benefits. The jury found that plaintiffs failed to prove Bayer misrepresented its product claims or that consumers relied on false information when purchasing. |
| 2019 | Bayer and Johnson & Johnson settled approximately 25,000 lawsuits related to the blood thinner Xarelto by agreeing to pay $775 million to plaintiffs who claimed inadequate warnings about potential fatal bleeding risks. The companies did not admit liability and noted their success in six previous trials. |
| 2019 | Bayer increased annual revenue to €43.5 billion, with a significant improvement in net income to €4.0 billion, while employee count decreased to 103,824 |
| 2019 | Bayer identified key growth products including Xarelto, Eylea, Stivarga, Xofigo, and Adempas. |
| September 2019 | Bayer announced a significant organizational restructuring, reducing the number of management board members from seven to five to cut overall costs. |
| September 16 2019 | Bayer completes the merger of Monsanto India under the approval of National Company Law Tribunal. |
| August 2019 | Bayer acquired the remaining ≈60% of BlueRock Therapeutics for up to $600 million. |
| May 13 2019 | A United States Superior Court Judge initially ordered Bayer to pay more than $2.5 billion in damages to a California couple who contracted non-Hodgkin's Lymphoma, later reduced to $87 million on appeal. |
| 2018 | Bayer reported annual revenue of €39.5 billion, with a net income of €1.6 billion and 107,894 employees |
| November 2018 | Monsanto appealed the judgment, requesting a motion for a new trial. |
| November 2018 | Bayer's market capitalization was valued at US€65.4 billion in November, with company shares trading at over €69 per share. |
| September 18 2018 | Bayer filed an appeal against the Roundup lawsuit verdict. The award was subsequently reduced to $78.5 million. |
| August 2018 | A U.S. jury ordered Monsanto (recently acquired by Bayer) to pay $289 million to a school groundskeeper who claimed his Non-Hodgkin's lymphoma was caused by Roundup, resulting in a 14% drop in Bayer's share price. |
| June 7 2018 | Bayer closes the Monsanto acquisition, discontinuing the Monsanto brand and marketing products under the Bayer name. |
| May 20 2018 | United States approves the Bayer-Monsanto acquisition deal. |
| March 21 2018 | European Union approves the Bayer-Monsanto acquisition deal. |
| 2017 | US District Court in San Francisco determined that subclasses of purchasers of One A Day vitamins from Florida, New York, and California could act together in a class action lawsuit against Bayer. |
| 2017 | Bayer reported annual earnings of EUR€7.3 billion and annual revenue of EUR€35 billion, experiencing a 25.1% decrease from the previous fiscal cycle. |
| 2016 | Bayer began a second restructuring with the aim of transitioning to a life sciences-based company, planning to offload its Materials division by mid-2016. |
| September 2016 | Monsanto agrees to Bayer's revised $66 billion acquisition offer. |
| May 2016 | Bayer initially offers to buy U.S. biotechnology company Monsanto for $62 billion, which Monsanto initially rejects. |
| September 2015 | Bayer formally spun out Covestro as a separate company. |
| June 2015 | Bayer agreed to sell its diabetic care business to Panasonic Healthcare Holdings for $1.02 billion. |
| June 1 2015 | Bayer announced that the spun-off MaterialScience business would be named Covestro. |
| 2014 | Bayer agreed to buy Merck's consumer health business for $14.2 billion, gaining control of brands like Claritin, Coppertone, and Dr. Scholl's, positioning itself second globally in nonprescription drugs. |
| 2014 | Bayer acquired Algeta, a radiotherapeutic company, for approximately $2.9 billion. |
| 2014 | Pharmaceutical products contributed €12.05 billion of Bayer's total €40.15 billion gross revenue. |
| September 18 2014 | Bayer AG's Board of Directors announced plans to float the Bayer MaterialScience business as a separate entity on the stock market. |
|
We are only showing the most recent entries for this topic. |
|
This contents of the box above is based on material from the Wikipedia article Bayer, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.